gASCA

check icon Optimal Result: 0 - 45 Units.

This marker is usually part of a test called IBD Expanded Panel (IBD = Inflammatory Bowel Disease) and aids in the diagnosis of inflammatory bowel disease and the differential diagnosis of Crohn’s disease (CD) and ulcerative colitis (UC); it is also a prognostic aid for clinical management of patients with CD.

What is IBD?

Inflammatory bowel disease is a chronic disorder of the lower gastrointestinal tract that may occur in three forms:

- Crohn’s disease (CD),

- Ulcerative colitis (UC),

- and Indeterminate colitis (IC).

How to diagnose IBD?

Its prevalence in the adult population approaches 0.3%. The differential diagnosis of the different forms of IBD is often difficult, time-consuming, and invasive. The gold standard for diagnosis is endoscopy with biopsies for histologic examination.

In recent years, however, a number of serological markers have been introduced. The most commonly employed serological markers of IBD are:

anti-Saccharomyces cerevisiae antibody (ASCA) and

- atypical perinuclear antineutrophil cytoplasmic antibody (pANCA).

ASCA positivity is found predominantly in patients with Crohn’s disease (CD), while pANCA positivity is found predominantly in patients with Ulcerative colitis (UC).

A combination of ASCA and pANCA has a specificity of as high as 99% for differentiation of CD from UC. Nevertheless, there are a substantial number of patients with IBD who are negative for both. The addition of novel serological markers improves the sensitivity of the conventional ASCA/pANCA combination.

About two-thirds of patients with CD develop either a stricturing or penetrating disease course within 10 years after diagnosis. As many as 80% of all CD patients undergo surgery at least once during the course of their disease. Consequently, the identification of individuals susceptible to the development of more complicated disease behavior would allow for earlier and more aggressive treatment.

The IBD Expanded Panel test offers three novel markers:

- antichitobioside IgA (ACCA),

- antilaminaribioside IgG (ALCA),

- antimannobioside IgG (AMCA),

together with anti-Saccharomyces cerevisiae IgG (gASCA) and pANCA.

These markers provide additional diagnostic and prognostic information depending on the combination of results.

The antibodies included in the panel are:

- ASCA (anti-Saccharomyces cerevisiae antibodies),

- ALCA (antilaminaribioside carbohydrate antibodies),

- ACCA (antichitobioside carbohydrate antibodies),

AMCA (antimannobioside carbohydrate antibodies).

Numerous studies of CD have demonstrated an association between ileal disease (ileal = last part of the small intestine) and the presence of ACCA, ALCA, AMCA, and ASCA. Among these antibodies, the association with localization to the small intestine increased with the number of positive antibodies and with the concentration of individual antibodies. A more aggressive or complicated disease course in CD (as indicated by stricturing or perforation of the intestine or need for surgery), has also been associated with the presence of ACCA, ALCA, AMCA, and ASCA. Among these antibodies, the association with complicated disease behavior or surgery increased with the number and concentration of antibodies.

What does it mean if your gASCA result is too high?

How to interpret your results:

###Please look at all markers of this report together###

When the only positive marker is pANCA, the interpretive comment on the report will read: "Suggestive of ulcerative colitis."

When only one of ACCA, ALCA, AMCA, or gASCA is positive and pANCA is negative, the interpretive comment will read: "Suggestive of Crohn's disease. Pattern is not conclusive for disease behavior risk stratification."

When only one of ACCA, ALCA, AMCA, or gASCA is positive and pANCA is positive, the interpretive comment will read: "Suggestive of inflammatory bowel disease. Pattern is not conclusive for any specific disease form."

When any two of ACCA, ALCA, AMCA, or gASCA are positive and pANCA is positive or negative, the interpretive comment will read: "Suggestive of Crohn's disease with high risk of aggressive disease behavior (development of strictures or fistulae)."

When any three or more of ACCA, ALCA, AMCA, or gASCA are positive and pANCA is positive or negative, the interpretive comment will read: "Suggestive of Crohn's disease with the very high risk of aggressive disease behavior (development of strictures or fistulae)."

When all markers are negative, the interpretive comment on the report will read: "Pattern is not suggestive of inflammatory bowel disease."

------------

Numerous studies of CD have demonstrated an association between ileal disease (ileal = last part of the small intestine) and the presence of ACCA, ALCA, AMCA, and ASCA. Among these antibodies, the association with localization to the small intestine increased with the number of positive antibodies and with the concentration of individual antibodies. A more aggressive or complicated disease course in CD (as indicated by stricturing or perforation of the intestine or need for surgery), has also been associated with the presence of ACCA, ALCA, AMCA, and ASCA. Among these antibodies, the association with complicated disease behavior or surgery increased with the number and concentration of antibodies.

------------

If gASCA levels are elevated in an IBD Expanded Panel, it may suggest a greater likelihood of Crohn's Disease. However, the presence of ASCA alone is not definitive for diagnosing Crohn's Disease. It's usually considered alongside other clinical findings, symptoms, and test results.

-------------

More about Crohn's Disease:

Crohn's disease is a chronic inflammatory bowel disease (IBD) characterized by inflammation of the gastrointestinal (GI) tract. It can affect any part of the GI tract from the mouth to the anus, but most commonly it affects the end of the small intestine and the beginning of the large intestine. Symptoms can vary but often include abdominal pain, diarrhea, fatigue, weight loss, and malnutrition. The exact cause of Crohn's disease is unknown, but it is believed to result from an interaction of genetic, environmental, and immune factors. The inflammation caused by Crohn's disease can be painful and debilitating, and may lead to life-threatening complications. While there is no cure, treatments are available that can greatly reduce the symptoms and even bring about long-term remission. These treatments include medication, lifestyle changes, and sometimes surgery. Management of the disease requires a comprehensive approach and is often tailored to the individual patient's needs.

-------------

It's important to understand that elevated gASCA levels are a biomarker and not a direct cause of symptoms or disease. Therefore, the treatment focuses on managing Crohn's disease itself rather than specifically targeting the elevated gASCA levels. Here are general approaches to treating Crohn's disease:

  1. Medication:

    • Aminosalicylates: Used for mild to moderate symptoms.
    • Corticosteroids: For reducing inflammation in moderate to severe cases.
    • Immunomodulators: These drugs suppress the immune system and are used for patients who don't respond to other treatments.
    • Biologic Therapies: These are newer drugs that target specific pathways in the immune system and are often effective in treating Crohn's disease.
  2. Diet and Nutrition Management:

    • Some patients benefit from dietary changes, although there's no one-size-fits-all diet for Crohn's disease.
    • Nutritional support, like supplements, may be needed, especially if the disease interferes with nutrient absorption.
  3. Lifestyle Changes:

    • Reducing stress, as stress can aggravate symptoms.
    • Quitting smoking, which is particularly important as smoking can exacerbate Crohn's disease.
  4. Surgery:

    • In cases where medication is not effective, surgery to remove a damaged portion of the GI tract may be necessary.
  5. Regular Monitoring:

    • Regular check-ups and tests to monitor the disease and adjust treatments as needed.

Remember, treatment for Crohn's disease is highly individualized and depends on the severity and location of the disease, as well as the patient's overall health and response to treatment. It's crucial to work closely with a gastroenterologist to develop a tailored treatment plan. Additionally, ongoing research may continue to provide new insights and treatments for Crohn's disease, so staying informed about the latest developments is beneficial.

All Your Lab Results.
One Simple Dashboard.

What does it mean if your gASCA result is too low?

How to interpret your results:

###Please look at all markers of this report together###

When the only positive marker is pANCA, the interpretive comment on the report will read: "Suggestive of ulcerative colitis."

When only one of ACCA, ALCA, AMCA, or gASCA is positive and pANCA is negative, the interpretive comment will read: "Suggestive of Crohn's disease. Pattern is not conclusive for disease behavior risk stratification."

When only one of ACCA, ALCA, AMCA, or gASCA is positive and pANCA is positive, the interpretive comment will read: "Suggestive of inflammatory bowel disease. Pattern is not conclusive for any specific disease form."

When any two of ACCA, ALCA, AMCA, or gASCA are positive and pANCA is positive or negative, the interpretive comment will read: "Suggestive of Crohn's disease with high risk of aggressive disease behavior (development of strictures or fistulae)."

When any three or more of ACCA, ALCA, AMCA, or gASCA are positive and pANCA is positive or negative, the interpretive comment will read: "Suggestive of Crohn's disease with the very high risk of aggressive disease behavior (development of strictures or fistulae)."

When all markers are negative, the interpretive comment on the report will read: "Pattern is not suggestive of inflammatory bowel disease."

Laboratories

Bring All Your Lab Results Together — In One Place

We accept reports from any lab, so you can easily collect and organize all your health information in one secure spot.

lab corp logo
genova diagnostics logo
quest diagnostics logo
dutch test logo
doctors data logo
vibrant america logo
diagnostic solutions logo
zrt laboratory logo
the great plains laboratory logo
cyrex laboratories logo
spectracell logo

Pricing Table

decoration

Personal plans

$15/ month

Complete Plan

Access your lab reports, explanations, and tracking tools.

  • Import lab results from any provider
  • Track all results with visual tools
  • Customize your reference ranges
  • Export your full lab history anytime
  • Share results securely with anyone
  • Begin with first report entered
  • Cancel or upgrade anytime

$250/ once

Unlimited Account

Pay once, access everything—no monthly fees, no limits.

  • Import lab results from any provider
  • Track all results with visual tools
  • Customize your reference ranges
  • Export your full lab history anytime
  • Share results securely with anyone
  • Receive 10 reports entered for you
  • Skip the $15/month subscription — no recurring payments ever

$45/ month

Pro Monthly

Designed for professionals managing their clients' lab reports

  • Import lab results from any provider
  • Track lab results for multiple clients
  • Customize reference ranges per client
  • Export lab histories and reports
  • Begin with first report entered by us
  • Cancel or upgrade anytime

About membership

What's included in a Healthmatters membership

microscope icon Import Lab Results from Any Source

person icon See Your Health Timeline

book icon Understand What Your Results Mean

textbook icon

textbook icon Visualize Your Results

folder icon

folder icon

card icon Securely Share With Anyone You Trust

Let Your Lab Results Tell the Full Story

What Healthmatters Members Are Saying

5 stars rating

I have been using Healthmatters.io since 2021. I travel all over the world and use different doctors and health facilities. This site has allowed me to consolidate all my various test results over 14 years in one place. And every doctor that I show this to has been impressed. Because with  any health professional I talk to, I can pull up historical results in seconds. It is invaluable. Even going back to the same doctor, they usually do not have the historical results from their facility in a graph format. That has been very helpful.

Anthony

Unlimited Plan Member since 2021

5 stars rating

What fantastic service and great, easy-to-follow layouts! I love your website; it makes it so helpful to see patterns in my health data. It's truly a pleasure to use. I only wish the NHS was as organized and quick as Healthmatters.io. You've set a new standard for health tracking!

Karin

Advanced Plan Member since 2020

5 stars rating

As a PRO member and medical practitioner, Healthmatters.io has been an invaluable tool for tracking my clients' data. The layout is intuitive, making it easy to monitor trends and spot patterns over time. The ability to customize reports and charts helps me present information clearly to my clients, improving communication and outcomes. It's streamlined my workflow, saving me time and providing insights at a glance. Highly recommended for any practitioner looking for a comprehensive and user-friendly solution to track patient labs!

Paul

Healthmatters Pro Member since 2024

Use promo code to save 10% off any plan.

Frequently asked questions

Healthmatters is a personal health dashboard that helps you organize and understand your lab results. It collects and displays your medical test data from any lab in one secure, easy-to-use platform.

  • Individuals who want to track and understand their health over time.
  • Health professionals, such as doctors, nutritionists, and wellness coaches, need to manage and interpret lab data for their clients.

With a Healthmatters account, you can:

  • Upload lab reports from any lab
  • View your data in interactive graphs, tables, and timelines
  • Track trends and monitor changes over time
  • Customize your reference ranges
  • Export and share your full lab history
  • Access your results anytime, from any device

Professionals can also analyze client data more efficiently and save time managing lab reports.

Healthmatters.io personal account provides in-depth research on 4000+ biomarkers, including information and suggestions for test panels such as, but not limited to:

  • The GI Effects® Comprehensive Stool Profile,
  • GI-MAP,
  • The NutrEval FMV®,
  • The ION Profile,
  • Amino Acids Profile,
  • Dried Urine Test for Comprehensive Hormones (DUTCH),
  • Organic Acids Test,
  • Organix Comprehensive Profile,
  • Toxic Metals,
  • Complete Blood Count (CBC),
  • Metabolic panel,
  • Thyroid panel,
  • Lipid Panel,
  • Urinalysis,
  • And many, many more.

You can combine all test reports inside your Healthmatters account and keep them in one place. It gives you an excellent overview of all your health data. Once you retest, you can add new results and compare them.

If you are still determining whether Healthmatters support your lab results, the rule is that if you can test it, you can upload it to Healthmatters.

shield icon

We implement proven measures to keep your data safe.

At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.

gdpr compliance image hipaa compliance image